Compounds for Immunotherapy of Prostate Cancer.

摘要

A polypeptide composed of the immune part or variant of prostate protein, wherein the protein comprises a series of amino acids, encoded by DNA molecules, and a selected chain in the nucleoside chain group listed in SEQ No. 2, 3 and 8, 29, 41-45, 47, 52, 54-65, 7 o, 73-74, 79, 81, 87, 90, 92, 93, 97, 103, 104, 107, 109-111, 115-160, 171, 173, 175 and 177,The appendages of these nuclear chains and variants of the same chain. The DNA molecule consists of a nucleoside chain that encodes the polypeptide in requirement 1. 1. Pharmacological compounds for the treatment of prostate cancer, including a polypeptide and a carrier without physiological rejection, in which the polypeptide includes the immune part of prostate protein or its variants,The protein consists of an amino acid chain encoded by a DNA molecule, which is supplemented by a selected chain in the nuclear chain set of SEQ No. 5-7, 30, 40, 46, 53, 66-69, 71, 72, 75, 78, 80, 82-86, 88, 89, 91, 94-96, 98-102, 105, 106 and 161-170. Nuclear chain and variants of the same chain. 1. Vaccines for prostate cancer, including a peptide and a non-specific immune response enhancer, in which the peptide includes the immune part or variant of prostate protein,The protein consists of an amino acid chain encoded by a DNA molecule with a selected chain in the nuclear chain set of SEQ No. 5-7, 30, 40, 46, 53, 66-69, 71, 72, 75, 78, 80, 82-86, 88, 89, 91, 94-96, 98-102, 105, 106 and 161-170, The appendages of these nuclear chains and variants of the same chain.